147 related articles for article (PubMed ID: 36144563)
1. Dosimetry of [
Orcutt KD; Henry KE; Habjan C; Palmer K; Heimann J; Cupido JM; Gottumukkala V; Cissell DD; Lyon MC; Hussein AI; Liu D; Li M; Johnson FL; Schultz MK
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144563
[TBL] [Abstract][Full Text] [Related]
2. Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma.
Li M; Liu D; Lee D; Cheng Y; Baumhover NJ; Marks BM; Sagastume EA; Ballas ZK; Johnson FL; Morris ZS; Schultz MK
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359580
[TBL] [Abstract][Full Text] [Related]
3. Development and dosimetry of
Dos Santos JC; Schäfer M; Bauder-Wüst U; Lehnert W; Leotta K; Morgenstern A; Kopka K; Haberkorn U; Mier W; Kratochwil C
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1081-1091. PubMed ID: 30603987
[TBL] [Abstract][Full Text] [Related]
4. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
5.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
Tafreshi NK; Tichacek CJ; Pandya DN; Doligalski ML; Budzevich MM; Kil H; Bhatt NB; Kock ND; Messina JL; Ruiz EE; Delva NC; Weaver A; Gibbons WR; Boulware DC; Khushalani NI; El-Haddad G; Triozzi PL; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
J Nucl Med; 2019 Aug; 60(8):1124-1133. PubMed ID: 30733316
[TBL] [Abstract][Full Text] [Related]
7. Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studies.
Máthé D; Szigeti K; Hegedűs N; Horváth I; Veres DS; Kovács B; Szűcs Z
Appl Radiat Isot; 2016 Aug; 114():1-6. PubMed ID: 27156049
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.
Li M; Liu D; Lee D; Kapoor S; Gibson-Corley KN; Quinn TP; Sagastume EA; Mott SL; Walsh SA; Acevedo MR; Johnson FL; Schultz MK
Mol Pharm; 2019 Sep; 16(9):3904-3915. PubMed ID: 31318566
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Evaluation of
Banerjee SR; Minn I; Kumar V; Josefsson A; Lisok A; Brummet M; Chen J; Kiess AP; Baidoo K; Brayton C; Mease RC; Brechbiel M; Sgouros G; Hobbs RF; Pomper MG
J Nucl Med; 2020 Jan; 61(1):80-88. PubMed ID: 31253744
[TBL] [Abstract][Full Text] [Related]
11. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
12. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
Hamacher KA; Sgouros G
Med Phys; 2001 Sep; 28(9):1857-74. PubMed ID: 11585217
[TBL] [Abstract][Full Text] [Related]
13. [
Chapeau D; Koustoulidou S; Handula M; Beekman S; de Ridder C; Stuurman D; de Blois E; Buchatskaya Y; van der Schilden K; de Jong M; Konijnenberg MW; Seimbille Y
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513897
[TBL] [Abstract][Full Text] [Related]
14. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Wiseman GA; White CA; Sparks RB; Erwin WD; Podoloff DA; Lamonica D; Bartlett NL; Parker JA; Dunn WL; Spies SM; Belanger R; Witzig TE; Leigh BR
Crit Rev Oncol Hematol; 2001; 39(1-2):181-94. PubMed ID: 11418315
[TBL] [Abstract][Full Text] [Related]
16. A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice.
Zaid NRR; Kletting P; Winter G; Prasad V; Beer AJ; Glatting G
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959413
[TBL] [Abstract][Full Text] [Related]
17. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.
Tafreshi NK; Silva A; Estrella VC; McCardle TW; Chen T; Jeune-Smith Y; Lloyd MC; Enkemann SA; Smalley KS; Sondak VK; Vagner J; Morse DL
Mol Pharm; 2013 Aug; 10(8):3175-85. PubMed ID: 23763620
[TBL] [Abstract][Full Text] [Related]
19. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
Essman SC; Lewis MR; Miller WH
J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
[TBL] [Abstract][Full Text] [Related]
20. Optimized Methods for the Production of High-Purity
Saini S; Bartels JL; Appiah JK; Rider JH; Baumhover N; Schultz MK; Lapi SE
J Nucl Med; 2023 Nov; 64(11):1791-1797. PubMed ID: 37652545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
